Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ess Tech Inc (NY: GWH )

0.7819 +0.0417 (+5.63%)
Streaming Delayed Price Updated: 12:34 PM EDT, May 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Ess Tech Inc

< Previous 1 2 3 4 5 Next >
Mid-Afternoon Market Update: R. R. Donnelley & Sons Surges Following Buyout Offer; Columbia Banking System Shares Slide
Toward the end of trading Tuesday, the Dow traded down 0.13% to 34,450.01 while the NASDAQ rose 0.01% to 14,486.37. The S&P also fell, dropping 0.10% to 4,356.92. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
GWH Stock: 11 Things to Know as ESS Tech Starts Trading Today
Here's what investors may want to know about the incredible start to trading for ESS Tech today as GWH stock soars. 
Via InvestorPlace
Topics Initial Public Offering
Exposures Securities Market
Mid-Day Market Update: Dow Falls 60 Points; Nutriband Shares Spike Higher
Midway through trading Tuesday, the Dow traded down 0.18% to 34,434.80 while the NASDAQ fell 0.14% to 14,466.15. The S&P also fell, dropping 0.19% to 4,352.77. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
30 Stocks Moving In Tuesday's Mid-Day Session
Gainers ESS Tech Inc (NYSE: GWH) shares jumped 96.4% to $20.46. ESS Inc, the Bill Gates-backed battery maker went public on the New York Stock Exchange on Monday after... 
Via Benzinga
This Bill Gates-Backed Renewable Energy Company Has Skyrocketed On NYSE Debut After SPAC Merger
ESS Inc (NYSE: GWH), the Bill Gates-backed battery maker went public on the New York Stock Exchange on Monday after completing a slated business combination with special... 
Via Benzinga
46 Biggest Movers From Yesterday
Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares jumped 93.9% to close at $35.36 on Monday. The FDA removed the full clinical hold on Protagonist Therapeutics’... 
Via Benzinga
Exposures Product Safety
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.